News
Resources
Blog
Sites
IP Explained: How does the U.S. patent process work?
By Megan Van Etten | June 24, 2021
Have you ever used a Teflon-coated pan or hit a golf ball down the fairway? Had a friend or family member receive treatment with a new medication? All these products were developed because patents...
Read More
Building a better health care system: A conversation with Mark Reisenauer, President of Astellas US
By Stephen J. Ubl | June 23, 2021
Our industry continues to work tirelessly to combat the COVID-19 virus by developing effective therapeutics to treat COVID-19 and vaccines to prevent future infections. As we continue our efforts...
Read More
More than 800 medicines are in development for diseases that disproportionately affect racial and ethnic communities
By Andrew Powaleny | June 22, 2021
We are in a new era of medicine where groundbreaking biopharmaceutical research and development is transforming medicine, but these innovations are meaningless if they don’t reach patients,...
Read More
Researchers to shine light on biopharmaceutical R&D with policymakers
By Andrew Powaleny | June 15, 2021
Today, biopharmaceutical researchers from PhRMA member companies are meeting virtually with members of Congress and staff to share their stories of transforming game-changing scientific...
Read More
How research evolves and brings new hope to patients
By Stephen J. Ubl | June 11, 2021
Before medicines can be made available to patients, they often begin as ideas that are based on newly discovered molecules and cells, strange phenomena or little-understood processes in the body....
Read More
Continued R&D into Alzheimer’s disease means hope for patients, families and caregivers
By Richard Moscicki, M.D. | June 4, 2021
More than 6 million Americans, most of them age 65 or older, live with Alzheimer’s disease, a devastating degenerative brain disease and the most common form of dementia. After heart disease and...
Read More
By
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
New report demonstrates development of new medicines relies on private sector expertise and investment
By John Corea | May 10, 2021
America’s biopharmaceutical companies are at the heart of a research and development (R&D) ecosystem that develops more innovative medicines than any other country in the world. Critical to this...
Read More
Reflecting on Mental Health Awareness Month
By Andrew Powaleny | May 4, 2021
As communities around the world continue to grapple with the impact of COVID-19, the importance of furthering our understanding of the impact on our mental health is undeniable.
Read More
New PhRMA report shows nearly 90 medicines in development to fight drug-resistant infections, but future pipeline remains challenging
By Andrew Powaleny | April 29, 2021
The discovery and introduction of antibiotics in the 1940s transformed modern medicine and enabled tremendous progress in health care and life expectancy. Today, this progress is being threatened...
Read More
Medicare Monday (100)
340B Spotlight (46)
Cost & Consequence (0)
